Rani Therapeutics Holdings, Inc. (RANI) (CIK 0001856725) CORRESP

Rani Therapeutics Holdings, Inc. (RANI) (CIK 0001856725) → SEC staff · filed 2025-12-01 · ticker RANI · SIC 2834 · view PDF on sec.gov ↗
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

Key facts

Accession number
0001193125-25-303863
Form
CORRESP
Filer
Rani Therapeutics Holdings, Inc. (RANI) (CIK 0001856725)
CIK
0001856725
Ticker
RANI
Filed
2025-12-01
SIC industry
2834
HQ
San Jose, CA

Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1856725/000119312525303863/filename1.htm

EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗